-
Specialties
Board Certification
American Board of Internal Medicine (Internal Medicine)American Board of Internal Medicine (Sub: Hematology)American Board of Internal Medicine (Sub: Medical Oncology)Patient Rating
4.9 /5( out of 21 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
November 18, 2024HUNTSMAN CANCER CENTERDr. Baron is excellent in every respect.
November 17, 2024HUNTSMAN CANCER CENTERDoctor Baron is great! My visit with her and her staff went very well.
November 09, 2024HUNTSMAN CANCER CENTERDr Baron was extremely supportive and explained my condition in terms I could easily understand. She was able to answer my questions and explained very well the prognosis of my case and me understand how to handle the other issues I am going through. She was extremely courteous and friendly.
November 06, 2024HUNTSMAN CANCER CENTERprofoundly competent, cheerful, compassionate and kind, thorough, and professional.
October 07, 2024HUNTSMAN CANCER CENTERShe was very professional and very knowledgeable . She explained everything in full detail. She made me feel very comfortable with my choice to have her as my oncologist
October 07, 2024HUNTSMAN CANCER CENTERVery detailed Exam , with frank comments. Top Draw Doctor,and I have been to a few !
October 06, 2024HUNTSMAN CANCER CENTERDoctor Baron is a superb provider who listens, responds with intelligent suggestions and advice and contemplates the implications of patient input and test results. I have to believe that oncology is challenging both intellectually and emotionally and I hope that someone so dedicated and committed to her field can stay the course. We will all benefit.
September 21, 2024HUNTSMAN CANCER CENTERDr Baron explained everything to me thoroughly and carefully; she listened and answered all of my questions. She demonstrated great care and concern throughout my visit. I felt comfortable and confident during my time with her.
September 21, 2024HUNTSMAN CANCER CENTERDoctor Baron was very informative about what to expect and explained everything in full detail.
-
Board Certification and Academic Information
Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions Hematology & Hematologic Malignancies
Board Certification American Board of Internal Medicine (Internal Medicine)American Board of Internal Medicine (Sub: Hematology)American Board of Internal Medicine (Sub: Medical Oncology)Education history
Fellowship Hematology & Oncology - Huntsman Cancer Institute/University of Utah Spencer Fox Eccles School of Medicine Chief Fellow Fellowship Hematology & Oncology - Huntsman Cancer Institute/University of Utah Spencer Fox Eccles School of Medicine Fellow Residency Internal Medicine - University of Utah School of Medicine Resident Professional Medical Medicine - University of Toledo College of Medicine and Life Sciences M.D. Undergraduate Advanced Spanish Study Abroad Program - La Universidad de Gran Rosario Undergraduate Spanish - Ohio State University, Honors College B.A. Undergraduate Biology - Ohio State University, Honors College B.S. Selected Publications
Journal Article
- Gociman S, Baron K, Hu B, Zussman J, Madigan LM (2022). Blistering Lesions Associated With Loncastuximab Tesirine. JAMA Dermatol, 158(7), 831-832. (Read full article)
- Baron MK, Wang X, Nevala-Plagemann C, Moser JC, Haaland B, Garrido-Laguna I (2021). Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma. Pancreas, 50(6), 796-802. (Read full article)
- Baron K, Moser JC, Patel S, Grossmann KF, Colonna SV, Hyngstrom JR (2020). Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies. J Oncol Pharm Pract, 27(3), 555-559. (Read full article)
- Carlson SJ, Fleig A, Baron MK, Berg IA, Alber BE (2019). Barriers to 3-Hydroxypropionate-Dependent Growth of Rhodobacter sphaeroides by Distinct Disruptions of the Ethylmalonyl Coenzyme A Pathway. J Bacteriol, 201(4). (Read full article)
Letter
- Baron MK, Osborn JD, Tao R, Lee CJ (2019). Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome. [Letter to the editor]. Leuk Lymphoma, 61(1), 231-233. (Read full article)
( out of 21 reviews )